Conserved and variant epitopes of Plasmodium vivax duffy binding protein as targets of inhibitory monoclonal antibodies

Infection and Immunity

Volumn 80, Issue 3, 2012, Pages 1203-1208

  Ntumngia, Francis B ^a   Schloegel, Jesse ^a,e   Barnes, Samantha J ^a   Mchenry, Amy M ^a,f   Singh, Sanjay ^d   King, Christopher L ^b,c   Adams, John H ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d Gennova Biopharmaceuticals Ltd   (India)

^e LA TROBE UNIVERSITY   (Australia)

^f Southwestern Adventist University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY BINDING PROTEIN; DUFFY BINDING PROTEIN II; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1D2; MONOCLONAL ANTIBODY 2A6; MONOCLONAL ANTIBODY 2C6; MONOCLONAL ANTIBODY 2D10; MONOCLONAL ANTIBODY 2F12; MONOCLONAL ANTIBODY 2H2; MONOCLONAL ANTIBODY 3A4; MONOCLONAL ANTIBODY 3C9; MONOCLONAL ANTIBODY 3D10; MONOCLONAL ANTIBODY 3F11; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BINDING ASSAY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; IN VITRO STUDY; NONHUMAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN TARGETING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; NEUTRALIZATION TESTS; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE;

EID: 84863257778     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05924-11     Document Type: Article

References (37)

1. Adams JH, et al. 1990. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63:141-153.
2. Adams JH, et al. 1992. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. U. S. A. 89:7085-7089.
3. Anders RF, et al. 1998. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16:240-247.
4. Batchelor JD, Zahm JA, Tolia NH. 2011. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat. Struct. Mol. Biol. 18:908-914.
5. Camus D, Hadley TJ. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230:553-556.
6. Ceravolo IP, et al. 2009. Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin. Exp. Immunol. 156:502-510.
7. Ceravolo IP, et al. 2008. Inhibitory properties of the antibody response to Plasmodium vivax Duffy binding protein in an area with unstable malaria transmission. Scand. J. Immunol. 67:270-278.
8. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH. 1996. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 184:1531-1536.
9. Chitnis CE, Miller LH. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180:497-506.
10. Chootong P, et al. 2010. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 78:1089-1095.
11. Cole-Tobian J, King CL. 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol. Biochem. Parasitol. 127:121-132.
12. Cole-Tobian JL, et al. 2009. Strain-specific Duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous Plasmodium vivax strains in Papua New Guinean children. Infect. Immun. 77:4009-4017.
13. Coley AM, et al. 2006. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasioninhibitory antibody. Infect. Immun. 74:2628-2636.
14. Crewther PE, Matthew ML, Flegg RH, Anders RF. 1996. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:3310-3317.
15. Fitch WM, Leiter JM, Li XQ, Palese P. 1991. Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 88:4270-4274.
16. Fraser TS, Kappe SH, Narum DL, VanBuskirk KM, Adams JH. 2001. Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells. Mol. Biochem. Parasitol. 117:49-59.
17. Grimberg BT, et al. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 4:e337.
18. Haynes JD, et al. 1988. Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J. Exp. Med. 167:1873-1881.
19. King CL, et al. 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U. S. A. 105:8363-8368.
20. Mayer DC, et al. 2004. Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. Proc. Natl. Acad. Sci. U. S. A. 101:2518-2523.
21. Mendis K, Sina BJ, Marchesini P, Carter R. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
22. Michon P, Fraser T, Adams JH. 2000. Naturally acquired and vaccineelicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 68:3164-3171.
23. Michon P, et al. 2001. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection. FEBS Lett. 495:111-114.
24. Michon PA, Arevalo-Herrera M, Fraser T, Herrera S, Adams JH. 1998. Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village. Am. J. Trop. Med. Hyg. 59:597-599.
25. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.
26. Ntumngia FB, et al. 2009. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am. J. Trop. Med. Hyg. 80:218-227.
27. Singh S, et al. 2001. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. J. Biol. Chem. 276:17111-17116.
28. Tolia NH, Enemark EJ, Sim BK, Joshua-Tor L. 2005. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122:183-193.
29. Tran TM, et al. 2005. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. Cytometry A 63:59-66.
30. Tsuboi T, et al. 1994. Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect. Immun. 62:5581-5586.
31. VanBuskirk KM, et al. 2004. Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J. Infect. Dis. 190:1556-1562.
32. VanBuskirk KM, Sevova E, Adams JH. 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U. S. A. 101:15754-15759.
33. Welch SG, McGregor IA, Williams K. 1977. The Duffy blood group and malaria prevalence in Gambian West Africans. Trans. R. Soc. Trop. Med. Hyg. 71:295-296.
34. Wickramarachchi T, Devi YS, Mohmmed A, Chauhan VS. 2008. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. PLoS One 3:e1732.
35. Wilson IA, Cox NJ. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
36. Xainli J, et al. 2003. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein. Infect. Immun. 71:2508-2515.
37. Yazdani SS, Shakri AR, Chitnis CE. 2004. A high cell density fermentation strategy to produce recombinant malarial antigen in E. coli. Biotechnol. Lett. 26:1891-1895.